FREE SHIPPING ON ORDERS OVER $150

lippard glutathione cisplatin A cisplatin-based platinum(IV) prodrug containing a s-transferase inhibitor to reverse cisplatin-resistance in non-small cell lung cancer New drug candidate shows promise

$29.83

Quantity
- +
Description

Perform Better with B12 The most reliable performance signal from B12 supplementation appears when correcting an existing deficiency rather than supplementing on top of adequate baseline

lippard glutathione cisplatin A cisplatin-based platinum(IV) prodrug containing a s-transferase inhibitor to reverse cisplatin-resistance in non-small cell lung cancer New drug candidate shows promise

302 , C1045C1054 (2012)

lippard glutathione cisplatin A cisplatin-based platinum(IV) prodrug containing a s-transferase inhibitor to reverse cisplatin-resistance in non-small cell lung cancer New drug candidate shows promise

Multitarget strategies to reduce myocardial ischemia/reperfusion injury: JACC review topic of the week

lippard glutathione cisplatin A cisplatin-based platinum(IV) prodrug containing a s-transferase inhibitor to reverse cisplatin-resistance in non-small cell lung cancer New drug candidate shows promise

PMID: 7514244

lippard glutathione cisplatin A cisplatin-based platinum(IV) prodrug containing a s-transferase inhibitor to reverse cisplatin-resistance in non-small cell lung cancer New drug candidate shows promise

To Book Appointment

lippard glutathione cisplatin A cisplatin-based platinum(IV) prodrug containing a s-transferase inhibitor to reverse cisplatin-resistance in non-small cell lung cancer New drug candidate shows promise

You may also like

recommand products